AR054888A1 - Derivados de quinolina como agentes antibacterianos - Google Patents

Derivados de quinolina como agentes antibacterianos

Info

Publication number
AR054888A1
AR054888A1 ARP060103370A ARP060103370A AR054888A1 AR 054888 A1 AR054888 A1 AR 054888A1 AR P060103370 A ARP060103370 A AR P060103370A AR P060103370 A ARP060103370 A AR P060103370A AR 054888 A1 AR054888 A1 AR 054888A1
Authority
AR
Argentina
Prior art keywords
alkyl
compound
het
formula
agents
Prior art date
Application number
ARP060103370A
Other languages
English (en)
Spanish (es)
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35768115&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR054888(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of AR054888A1 publication Critical patent/AR054888A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4709Non-condensed quinolines and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • A61K31/53771,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ARP060103370A 2005-08-03 2006-08-02 Derivados de quinolina como agentes antibacterianos AR054888A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05107155 2005-08-03

Publications (1)

Publication Number Publication Date
AR054888A1 true AR054888A1 (es) 2007-07-25

Family

ID=35768115

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060103370A AR054888A1 (es) 2005-08-03 2006-08-02 Derivados de quinolina como agentes antibacterianos

Country Status (30)

Country Link
US (1) US8691800B2 (enExample)
EP (1) EP1912649B1 (enExample)
JP (1) JP5208739B2 (enExample)
KR (1) KR101413094B1 (enExample)
CN (1) CN101277698B (enExample)
AP (1) AP2483A (enExample)
AR (1) AR054888A1 (enExample)
AU (1) AU2006274873B2 (enExample)
BR (1) BRPI0614099B8 (enExample)
CA (1) CA2615900C (enExample)
CY (1) CY1113535T1 (enExample)
DK (1) DK1912649T3 (enExample)
EA (1) EA014834B1 (enExample)
ES (1) ES2397358T3 (enExample)
HR (1) HRP20120910T1 (enExample)
IL (1) IL189140A (enExample)
JO (1) JO2837B1 (enExample)
ME (1) ME01485B (enExample)
MX (1) MX2008001601A (enExample)
MY (1) MY147637A (enExample)
NO (1) NO342328B1 (enExample)
NZ (1) NZ566012A (enExample)
PL (1) PL1912649T3 (enExample)
PT (1) PT1912649E (enExample)
RS (1) RS52606B (enExample)
SI (1) SI1912649T1 (enExample)
TW (1) TWI385168B (enExample)
UA (1) UA95911C2 (enExample)
WO (1) WO2007014934A2 (enExample)
ZA (1) ZA200801106B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO2837B1 (en) 2005-08-03 2014-09-15 جانسن فارمسيتكا ان في Quinoline derivatives acting as antibacterial agents
JO3271B1 (ar) * 2006-12-06 2018-09-16 Janssen Pharmaceutica Nv مشتقات الكوينولين المضادة للجراثيم
JO2683B1 (en) * 2006-12-06 2013-03-03 جانسين فارماسوتيكا ان. في Quinoline antibacterial derivatives
JP5246715B2 (ja) 2009-01-27 2013-07-24 独立行政法人科学技術振興機構 蛋白質架橋阻害剤およびその用途
US9617244B2 (en) 2012-04-27 2017-04-11 Janssen Pharmaceutica Nv Antibacterial quinoline derivatives
PL2841425T3 (pl) 2012-04-27 2016-10-31 Antybakteryjne pochodne chinoliny
US10508097B2 (en) * 2016-03-07 2019-12-17 The Global Alliance For Tb Drug Development, Inc. Antibacterial compounds and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998018326A1 (en) * 1996-10-28 1998-05-07 Department Of The Army, U.S. Government Compounds, compositions and methods for treating antibiotic-resistant infections
US6103905A (en) * 1997-06-19 2000-08-15 Sepracor, Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
GB0101577D0 (en) * 2001-01-22 2001-03-07 Smithkline Beecham Plc Compounds
AR040336A1 (es) * 2002-06-26 2005-03-30 Glaxo Group Ltd Compuesto de piperidina, uso del mismo para la fabricacion de un medicamento, composicion farmaceutica que lo comprende y procedimiento para preparar dicho compuesto
DK2301544T3 (da) * 2002-07-25 2013-01-02 Janssen Pharmaceutica Nv Quinolinderivater som mellemprodukter til mykobakterielle inhibitorer
NZ547277A (en) * 2004-01-23 2009-08-28 Janssen Pharmaceutica Nv Substituted quinolines and their use as mycobacterial inhibitors
JO2837B1 (en) 2005-08-03 2014-09-15 جانسن فارمسيتكا ان في Quinoline derivatives acting as antibacterial agents

Also Published As

Publication number Publication date
EP1912649B1 (en) 2012-10-10
ME01485B (me) 2014-04-20
CY1113535T1 (el) 2016-06-22
IL189140A (en) 2014-07-31
WO2007014934A2 (en) 2007-02-08
US8691800B2 (en) 2014-04-08
PL1912649T3 (pl) 2013-03-29
DK1912649T3 (da) 2013-01-21
NO342328B1 (no) 2018-05-07
CN101277698B (zh) 2011-06-22
JP5208739B2 (ja) 2013-06-12
ZA200801106B (en) 2009-09-30
SI1912649T1 (sl) 2013-01-31
TW200800971A (en) 2008-01-01
AU2006274873A1 (en) 2007-02-08
WO2007014934A8 (en) 2007-05-18
MX2008001601A (es) 2008-02-19
HK1124232A1 (zh) 2009-07-10
EP1912649A2 (en) 2008-04-23
IL189140A0 (en) 2008-08-07
JO2837B1 (en) 2014-09-15
KR20080039961A (ko) 2008-05-07
US20080227775A1 (en) 2008-09-18
BRPI0614099B8 (pt) 2021-05-25
BRPI0614099A2 (pt) 2011-03-09
CA2615900A1 (en) 2007-02-08
CA2615900C (en) 2014-12-09
BRPI0614099B1 (pt) 2019-11-12
NZ566012A (en) 2011-02-25
CN101277698A (zh) 2008-10-01
AU2006274873B2 (en) 2012-12-13
TWI385168B (zh) 2013-02-11
EA200800513A1 (ru) 2008-06-30
ES2397358T3 (es) 2013-03-06
WO2007014934A3 (en) 2007-04-05
PT1912649E (pt) 2013-01-14
MY147637A (en) 2012-12-31
EA014834B1 (ru) 2011-02-28
JP2009503021A (ja) 2009-01-29
KR101413094B1 (ko) 2014-07-01
RS52606B (sr) 2013-04-30
AP2483A (en) 2012-10-01
HRP20120910T1 (hr) 2012-12-31
UA95911C2 (ru) 2011-09-26
NO20081068L (no) 2008-02-29

Similar Documents

Publication Publication Date Title
MY189118A (en) Pyrazolo[1,5-a]pyrazin-4-yl derivatives
CY1114908T1 (el) Παραγωγα κινολινης ως αντιβακτηριακοι παραγοντες
SV2008002969A (es) Derivados de pirimidina para el tratamiento del crecimiento celular anormal
EA200970535A1 (ru) Антибактериальные производные хинолина
EA200970534A1 (ru) Антибактериальные производные хинолина
WO2007014941A3 (en) Quinoline derivatives as antibacterial agents
PE20142421A1 (es) Fenilimidazopirazoles sustituidos y su uso
AR048573A1 (es) Compuesto de 8-azoniabiciclo[3.2.1]octano sustituido en la posicion 3, composicion farmceutica que lo comprende y su uso para preparar esta ultima
AR047466A1 (es) Compuestos derivados de 3h - imidazo[4,5 - b]piridina con actividad inhibidora de quinasa, composiciones farmacéuticas que los contienen como principio activo y su uso en la fabricacion de un medicamento para el tratatmiento de neoplasmas susceptibles.
NO20081068L (no) Kinolinderivater som antibakterielle midler
BRPI0515344A (pt) composto, composição farmacêutica, e, usos de uma quantidade eficaz de um composto 3-fosfoindol ou sal, pró-droga, estereoisÈmero, tautÈmero, n-óxido ou amina quaternária farmaceuticamente aceitável do mesmo e de uma quantidade de tratamento eficaz anti-hiv de um composto de 3-fosfoindol ou sal, pró-droga, estereo-isÈmero, tautÈmero, n-óxido ou amina quaternária farmaceuticamente aceitável do mesmo
WO2013106756A3 (en) Antimicrobial agents
EA200970536A1 (ru) Антибактериальные хинолиновые производные
NO20080481L (no) Kinolinderivater som antibakterielle midler
EA200970537A1 (ru) Антибактериальные производные хинолина
MY153291A (en) Quinoline derivatives as antibacterial agents
TNSN08093A1 (en) Quinoline derivatives and use as antitumor agents
EA200970496A1 (ru) Соединения 2-алкилиндазола для лечения некоторых расстройств цнс
TW200744596A (en) Antitumor agents
HK1112915A (en) Quinoline derivatives and use as antitumor agents
TH87170B (th) อนุพันธ์ควิโนลีนเป็นสารต้านแบคทีเรีย
WO2013052787A3 (en) Membrane activated chelators and use in the prevention and treatment of parasitic infection

Legal Events

Date Code Title Description
FB Suspension of granting procedure